Matches in Wikidata for { <http://www.wikidata.org/entity/Q71608753> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q71608753 description "artikull shkencor i botuar më 01 janar 1993" @default.
- Q71608753 description "artículu científicu espublizáu en xineru de 1993" @default.
- Q71608753 description "im Januar 1993 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71608753 description "scientific article published on 01 January 1993" @default.
- Q71608753 description "wetenschappelijk artikel" @default.
- Q71608753 description "наукова стаття, опублікована в січні 1993" @default.
- Q71608753 name "Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy" @default.
- Q71608753 name "Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy" @default.
- Q71608753 name "Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy" @default.
- Q71608753 type Item @default.
- Q71608753 label "Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy" @default.
- Q71608753 label "Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy" @default.
- Q71608753 label "Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy" @default.
- Q71608753 prefLabel "Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy" @default.
- Q71608753 prefLabel "Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy" @default.
- Q71608753 prefLabel "Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy" @default.
- Q71608753 P1433 Q71608753-71211999-596C-45C7-B957-4646CDD3C06C @default.
- Q71608753 P1476 Q71608753-1566760D-8329-4224-BB8D-214982A6E23B @default.
- Q71608753 P2093 Q71608753-20A86705-A058-4D0F-AC18-8DD4D4D8AFBE @default.
- Q71608753 P2093 Q71608753-4D9C6347-397B-41B1-B798-05101C6F18E1 @default.
- Q71608753 P2093 Q71608753-66D137A9-3134-472F-996A-FB5B1A73202B @default.
- Q71608753 P304 Q71608753-F4720FE4-AD28-4010-9086-B974574E1E76 @default.
- Q71608753 P31 Q71608753-56E02F2B-00DA-4C91-AD22-2833A742696F @default.
- Q71608753 P407 Q71608753-22A0BD2D-64D4-4190-B8F2-6C2AB1CD4162 @default.
- Q71608753 P478 Q71608753-1B5D35C1-1764-4A07-9E3F-0852E1337A62 @default.
- Q71608753 P577 Q71608753-9643833A-6D05-408F-9F70-DC65985ED683 @default.
- Q71608753 P698 Q71608753-86B78897-4175-408F-95BA-3188E52A3F54 @default.
- Q71608753 P698 7508049 @default.
- Q71608753 P1433 Q2125808 @default.
- Q71608753 P1476 "Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy" @default.
- Q71608753 P2093 "Busse R" @default.
- Q71608753 P2093 "Fleming I" @default.
- Q71608753 P2093 "Hecker M" @default.
- Q71608753 P304 "S31-6" @default.
- Q71608753 P31 Q13442814 @default.
- Q71608753 P407 Q1860 @default.
- Q71608753 P478 "22 Suppl 5" @default.
- Q71608753 P577 "1993-01-01T00:00:00Z" @default.
- Q71608753 P698 "7508049" @default.